Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients

American Journal of Ophthalmology

Volumn 128, Issue 1, 1999, Pages 8-14

  Toris, Carol B ^a   Camras, Carl B ^a   Yablonski, Michael E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE;

ADULT; AGED; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FLUOROPHOTOMETRY; GONIOSCOPY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; PATIENT SELECTION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; DOUBLE-BLIND METHOD; FEMALE; FLUOROPHOTOMETRY; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; QUINOXALINES; SCLERA; TIME FACTORS; VENOUS PRESSURE;

EID: 0033044222     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00076-8     Document Type: Article

References (33)

1. Nagasubramanian S., Hitchings R.A., Demailly P., et al. Comparison of apraclonidine and timolol in chronic open-angle glaucoma a three-month study . Ophthalmology. 100:1993;1318-1323.
2. Jampel H.D., Robin A.L., Quigley H.A., Pollack I.P. Apraclonidine a one-week dose-response study . Arch Ophthalmol. 106:1988;1069-1073.
3. Stewart W.C., Laibovitz R., Horwitz B., et al. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Arch Ophthalmol. 114:1996;938-942.
4. Gharagozloo N.Z., Relf S.J., Brubaker R.F. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology. 95:1988;1217-1220.
5. Koskela T., Brubaker R.F. Apraclonidine and timolol combined effects in previously untreated normal subjects . Arch Ophthalmol. 109:1991;804-806.
6. Mori M., Araie M. Effect of apraclonidine on blood-aqueous barrier permeability to plasma protein in man. Exp Eye Res. 54:1992;555-559.
7. Derick R.J., Robin A.L., Walters T.R., et al. Brimonidine tartrate a one-month dose response study . Ophthalmology. 104:1997;131-136.
8. Schuman J.S. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol. 41:(suppl):1996;S27-S37.
9. 2-adrenergic agonists B-HT 920 and UK 14304-18 effects on aqueous humor dynamics in monkeys . Arch Ophthalmol. 109:1991;1158-1162.
10. Schadlu R., Maus T.L., Nau C., Brubaker R.F. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans. Arch Ophthalmol. 116:1998;1441-1444.
11. Toris C.B., Tafoya M.E., Camras C.B., Yablonski M.E. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology. 102:1995;456-461.
12. Toris C.B., Gleason M.L., Camras C.B., Yablonski M.E. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 113:1995;1514-1517.
13. Schenker H.I., Yablonski M.E., Podos S.M., Linder L. Fluorophotometric study of epinephrine and timolol in human subjects. Arch Ophthalmol. 99:1981;1212-1216.
14. Zeimer R.C., Blair N.P., Cunha-Vaz J.G. Vitreous fluorophotometry for clinical research, I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol. 101:1983;1753-1756.
15. Yablonski M.E., Hayashi M., Cook D.J. Fluorophotometric study of intravenous carbonic anhydrase inhibitors in rabbits. Invest Ophthalmol Vis Sci. 28:1987;2076-2082.
16. Hayashi M., Yablonski M.E., Novack G.D. Trabecular outflow facility determined by fluorophotometry in human subjects. Exp Eye Res. 48:1989;621-625.
17. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
18. 2 agonist (UK14, 304-18) in cats, rabbits and monkeys. Curr Eye Res. 5:1986;665-676.
19. Burke J., Kharlamb A., Shan T., et al. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys a species difference . Reis D.J., Bousquet P., Parini A. The imidazoline receptor pharmacology, functions, ligands, and relevance to biology and medicine . 1995;78-95 The New York Academy of Sciences, New York.
20. Kharlamb A., Shan T., Runde E., Padillo E., Machado C., Burke J. The cynomolgus monkey has a CNS imidazoline receptor which mediates IOP and cardiovascular responses to AGN190342 (UK-14,304). Invest Ophthalmol Vis Sci. 33:1992;1115.
21. Gabelt B.T., Robinson J.C., Hubbard W.C., et al. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys. Exp Eye Res. 59:1994;633-644.
22. Schuman J.S., Horwitz B., Choplin N.T., et al. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension a controlled, randomized, multicenter clinical trial . Arch Ophthalmol. 115:1997;847-852.
23. Zhan G.-L., Toris C.B., Gaffney M.M., et al. Effects of apraclonidine and brimonidine on rabbit ocular blood flow. Invest Ophthalmol Vis Sci. 38:(suppl):1997;S783.
24. Lee P.-Y., Serle J.B., Podos S.M., Severin C. Time course of the effect of UK 14304-18 (brimonidine tartrate) on rabbit uveoscleral outflow. Invest Ophthalmol Vis Sci. 33:1992;1118.
25. Mishima H.K., Kiuchi Y., Takamatsu M., Rácz P., Bito L.Z. Circadian intraocular pressure management with latanoprost diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow . Surv Ophthalmol. 41:(suppl):1997;S139-S144.
26. 2α on aqueous humor dynamics in cynomolgus monkeys. Curr Eye Res. 6:1987;1035-1044.
27. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 49:1989;389-402.
28. 2α-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 48:1989;707-716.
29. 2α on uveoscleral outflow and outflow facility in the rabbit eye. Exp Eye Res. 54:1992;277-283.
30. Camras C.B., Podos S.M. The role of endogenous prostaglandin in clinically used and investigational glaucoma therapy. Bito L.Z., Stjernschantz J. The ocular effects of prostaglandins and other eicosanoids. 1989;459-475 Alan R. Liss, New York.
31. Kubo C., Suzuki R. Involvement of prejunctional alpha2-adrenoceptor in bovine ciliary muscle movement. J Ocular Pharmacol. 8:1992;225-231.
32. 2α-IE) on uveoscleral outflow. Bito L.Z., Stjernschantz J. The ocular effects of prostaglandins and other eicosanoids. 1989;429-436 Alan R. Liss, New York.
33. Townsend D.J., Brubaker R.F. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest Ophthalmol Vis Sci. 19:1980;256-266.